HER3-DXd
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HER3-DXd, covering 2026-01-28 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease [Phase 2]